CQ Pharmaceutical cancels supervisory board, approves share repurchase

CQ Pharmaceutical Holding Company announced results from its extraordinary shareholder meeting held July 28, where investors approved the cancellation of the company's supervisory board.

Shareholders also passed a comprehensive share repurchase program covering purchase methods, price range, funding sources and implementation timeline. All resolutions were approved as special resolutions with over two-thirds of valid votes.